RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Janssen Pharmaceutica N v patents

Recent patent applications related to Janssen Pharmaceutica N v. Janssen Pharmaceutica N v is listed as an Agent/Assignee. Note: Janssen Pharmaceutica N v may have other listings under different names/spellings. We're not affiliated with Janssen Pharmaceutica N v, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "J" | Janssen Pharmaceutica N v-related inventors




Date Janssen Pharmaceutica N v patents (updated weekly) - BOOKMARK this page
05/11/17Combination therapy for the treatment of diabetes
06/16/16Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
03/31/16Combination therapy for the treatment of diabetes
03/24/16Piperidine/piperazine derivatives
03/17/163-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors for the treatment of cancer
12/10/15Inhibitors of histone deacetylase
07/30/15Hetero-substituted acetanilide derivatives as analgesic agents
07/02/15Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
05/21/15Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
03/26/15Piperidine/piperazine derivatives
03/05/15Amino-derivatives as novel inhibitors of histone deacetylase
01/08/15Combination therapy for the treatment of diabetes
12/25/14Process for the preparation of protected l-alanine derivatives
10/16/14Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
06/19/14Inhibitors of histone deacetylase
06/12/14Isolated nucleic acid molecule encoding a neurotrophic growth factor
05/15/14Antifungal compositions with improved bioavailability
05/15/14Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
12/05/13Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
09/19/13Inhibitors of histone deacetylase
09/05/13Pyrido- and pyrimidopyrimidine derivatives as anti-profilerative agents
08/01/133-cyano-quinoline derivatives with antiproliferative activity
07/11/13Quinazoline derivatives
06/06/13Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
05/02/13Hetero-substituted acetanilide derivatives as analgesic agents
10/04/12Bicyclic thiazoles as allosteric modulators of mglur5 receptors
08/16/12Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
07/12/12Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
06/21/12Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
05/03/12Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/02/12Bicyclic benzamides of 3-or-4-substituted 4-(aminomethyl)-piperidine derivatives
12/15/11Radiolabelled pde10 ligands
11/24/11Methods of increasing platelet and hematopoietic stem cell production
09/29/11Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
08/18/11Isolated nucleic acid molecule encoding a neurotrophic growth factor
07/21/11Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators
06/23/11Biomarkers for assessing response to c-met treatment
05/19/11Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
03/31/111,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
03/31/11Cardiovascular safety assay
03/17/11Use of alpha-methylglucoside (amg) as an indicator for glucose absorption and excretion
11/25/10Modified poly(propylene-imine) dendrimers and their use as transfection agents for amionic bioactive factors ( as amended
11/18/10Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
10/07/10Pharmaceutical supply package
09/16/10Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/26/10Piperidine/piperazine derivatives
08/19/10Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives
07/22/10Piperidine/piperazine derivatives
07/08/10Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
06/03/10Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
04/22/10Formulations comprising triazoles and alkoxylated amines
03/11/104-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
02/25/10Antibacterial quinoline derivatives
02/04/10Substituted triazoline, tetrazolone and imidazolone derivatives for use as a medicine
11/05/09Biocidal combinations comprising imazalil
09/03/09Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists
07/30/09Pregelatinized starch in a controlled release formulation
05/14/09Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
05/14/09Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
04/30/09Substituted pyrazinone derivatives for use as a medicine
02/19/09Vagal afferent neurons as targets for treatment







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Janssen Pharmaceutica N v in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Janssen Pharmaceutica N v with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';